Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

ETIOLOGY AND CLINICAL CHARACTERISTICS OF MACULAR EDEMA IN PATIENTS WITH FAMILIAL EXUDATIVE VITREORETINOPATHY.

Rao P, Lertjirachai I, Yonekawa Y, Hasbrook M, Thomas BJ, Wood EH, Mehta N, Mane G, Drenser KA, Trese MT, Capone A Jr.

Retina. 2019 Aug 9. doi: 10.1097/IAE.0000000000002623. [Epub ahead of print]

PMID:
31404032
2.

Familial Exudative Vitreoretinopathy: Spectral-Domain Optical Coherence Tomography of the Vitreoretinal Interface, Retina, and Choroid.

Yonekawa Y, Thomas BJ, Drenser KA, Trese MT, Capone A Jr.

Ophthalmology. 2015 Nov;122(11):2270-7. doi: 10.1016/j.ophtha.2015.07.024. Epub 2015 Aug 20.

PMID:
26299697
3.

Early postoperative retinal thickness changes and complications after vitrectomy for diabetic macular edema.

Yamamoto T, Hitani K, Tsukahara I, Yamamoto S, Kawasaki R, Yamashita H, Takeuchi S.

Am J Ophthalmol. 2003 Jan;135(1):14-9.

PMID:
12504691
4.

[Combined pharmacosurgery as treatment for diabetic macular edema: core pars plana vitrectomy and intravitreal injection of bevacizumab and triamcinolone].

Naser H, Koss MJ, Singh P, Koch F.

Klin Monbl Augenheilkd. 2011 Oct;228(10):910-4. doi: 10.1055/s-0029-1245965. Epub 2011 Oct 13. German.

PMID:
21997827
5.

Vitreomacular traction as a consequence of posterior hyaloidal contraction after transpupillary thermotherapy.

Kashani AH, Aaberg TM Jr, Capone A Jr.

Am J Ophthalmol. 2013 May;155(5):937-45. doi: 10.1016/j.ajo.2012.11.017. Epub 2013 Jan 23.

PMID:
23352339
6.

Pars plana vitrectomy with internal limiting membranectomy for refractory diabetic macular edema without a taut posterior hyaloid.

Rosenblatt BJ, Shah GK, Sharma S, Bakal J.

Graefes Arch Clin Exp Ophthalmol. 2005 Jan;243(1):20-5. Epub 2004 Jul 31.

PMID:
15290152
7.
8.

Vitrectomy for diabetic macular edema: the role of posterior vitreous detachment and epimacular membrane.

Yamamoto T, Akabane N, Takeuchi S.

Am J Ophthalmol. 2001 Sep;132(3):369-77.

PMID:
11530050
9.

Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.

Haritoglou C, Kook D, Neubauer A, Wolf A, Priglinger S, Strauss R, Gandorfer A, Ulbig M, Kampik A.

Retina. 2006 Nov-Dec;26(9):999-1005.

PMID:
17151486
10.

RECALCITRANT CYSTOID MACULAR EDEMA AFTER PARS PLANA VITRECTOMY.

Alam MR, Arcinue CA, Mendoza NB, Freeman WR.

Retina. 2016 Jul;36(7):1244-51. doi: 10.1097/IAE.0000000000000892.

PMID:
26655611
11.

Distinctive mechanisms and patterns of exudative versus tractional intraretinal cystoid spaces as seen with multimodal imaging.

Govetto A, Sarraf D, Hubschman JP, Tadayoni R, Couturier A, Chehaibou I, Au A, Grondin C, Virgili G, Romano MR.

Am J Ophthalmol. 2019 Dec 17. pii: S0002-9394(19)30611-7. doi: 10.1016/j.ajo.2019.12.010. [Epub ahead of print]

PMID:
31862446
12.

Clinical characteristics and surgical management of familial exudative vitreoretinopathy-associated rhegmatogenous retinal detachment.

Chen SN, Hwang JF, Lin CJ.

Retina. 2012 Feb;32(2):220-5. doi: 10.1097/IAE.0b013e31821c3ec5.

PMID:
22277905
13.

INFLUENCE OF VITRECTOMY SURGERY ON THE INTEGRITY OF OUTER RETINAL LAYERS IN DIABETIC MACULAR EDEMA.

Uji A, Murakami T, Suzuma K, Yoshitake S, Arichika S, Ghashut R, Fujimoto M, Yoshimura N.

Retina. 2018 Jan;38(1):163-172. doi: 10.1097/IAE.0000000000001519.

PMID:
28263219
14.

Optical coherence tomography of idiopathic macular epiretinal membranes before and after surgery.

Massin P, Allouch C, Haouchine B, Metge F, Paques M, Tangui L, Erginay A, Gaudric A.

Am J Ophthalmol. 2000 Dec;130(6):732-9.

PMID:
11124291
15.

Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.

Ding X, Li J, Hu X, Yu S, Pan J, Tang S.

Retina. 2011 May;31(5):838-45. doi: 10.1097/IAE.0b013e3181f4420d.

PMID:
21293319
16.

[Pars plana vitrectomy and intravitreal triamcinolone for chronic pseudophakic cystoid macular edema].

Bencić G, Vatavuk Z, Mandić Z.

Acta Med Croatica. 2006;60(2):93-6. Croatian.

PMID:
16848195
17.

Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema.

Hartley KL, Smiddy WE, Flynn HW Jr, Murray TG.

Retina. 2008 Mar;28(3):410-9. doi: 10.1097/IAE.0b013e31816102f2.

PMID:
18327132
18.

[Vitrectomy for diabetic cystoid macular edema -- results of 72 cases].

Aboutable T, Kalvodova B.

Klin Monbl Augenheilkd. 2005 Aug;222(8):643-8. German.

PMID:
16118745
19.

Intravitreal anti-vascular endothelial growth factor for typical exudative age-related macular degeneration in eyes with good baseline visual acuity.

Chang YS, Han JI, Yoo SJ, Lew YJ, Kim JH.

Korean J Ophthalmol. 2014 Dec;28(6):466-72. doi: 10.3341/kjo.2014.28.6.466. Epub 2014 Nov 19.

20.

Long-term outcomes of pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema.

Yanyali A, Horozoglu F, Celik E, Nohutcu AF.

Retina. 2007 Jun;27(5):557-66.

PMID:
17558316

Supplemental Content

Support Center